ViaDerma Inc (VDRM)

[Batman412]

The remaining balance of promissory notes was due as of September 30, 2016 and the Company has been in
negotiations with the Holders of the promissory notes, but has not yet reached an agreement as to repayment schedule.
The Company recorded the default interest and penalty of the notes in amount of $97,249 during the year ended
December 31, 2015, and the accrued interest payable of $273,272 as of December 31, 2015.
On April 28, 2016, the Company filed Certificate of Amendment with the Secretary of State of Nevada to
increase its number of authorized common stock to 450,000,000 shares.
During the second quarter of 2016, we issued 7,750,000 shares of common stock to settle a portion of accrued
interest in amount of $3,875 at the conversion price of $0.0005 per share.
On June 14, 2016, one of the Note holders submitted a conversion notice to convert a portion of principal in
amount of $6,161 and accrued interest of $3,839 into 10,526,316 shares of common stock of the Company at the
conversion price of $0.00095 per share. The 10,526,316 shares were issued during the third quarter of 2016.
On July 8, 2016, we issued 12,000,000 shares of common stock to settle a portion of accrued interest in
amount of $6,000 at the conversion price of $0.0005 per share.
On July 22, 2016, we issued 10,526,316 shares of common stock to settle a portion of principal in amount
of $6,161 and accrued interest of $3,839 at the conversion price of $0.00095 per share.
In August of 2016, we issued total 45,000,000 shares of common stock to settle a portion of convertible